Market Tracker

07/25 6:05pm ET

Sunesis Pharmaceuticals Inc (NASDAQ:SNSS)

6.70
Data as of Jul 25
 +0.32 / +5.02%
Today’s Change
3.84
Today|||52-Week Range
7.49
+41.35%
Year-to-Date

Today’s Trading

Previous close6.38
Today’s open6.33
Day’s range6.25 - 6.73
Volume629,116
Average volume (3 months)414,439
Market cap$384.2M
Dividend yield--
Data as of 3:59pm ET, 07/25/2014

Growth & Valuation

Earnings growth (last year)+27.47%
Earnings growth (this year)-29.87%
Earnings growth (next 5 years)--
Revenue growth (last year)+111.93%
P/E ratioNM
Price/Sales31.13
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SUPNSupernus Pharmaceuti...-0.24-2.61%
SNTASynta Pharmaceutical...-0.04-0.98%
DRTXDurata Therapeutics ...-0.24-1.72%
DVAXDynavax Technologies...-0.03-2.13%
Data as of 4:00pm ET, 07/25/2014

Financials

Next reporting dateAugust 14, 2014
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$8.0M
Annual profit (last year)-$34.6M
Net profit margin-434.87%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel N. Swisher
CFO, Secretary &
EVP-Corporate Development
Eric H. Bjerkholt
Corporate headquarters
South San Francisco, California

Forecasts